These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10878300)

  • 21. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses.
    Morley PS; Townsend HG; Bogdan JR; Haines DM
    J Am Vet Med Assoc; 1999 Jul; 215(1):61-6. PubMed ID: 10397067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody responses after vaccination against equine influenza in the Republic of Korea in 2013.
    Kim EJ; Kim BH; Yang S; Choi EJ; Shin YJ; Song JY; Shin YK
    J Vet Med Sci; 2015 Nov; 77(11):1517-21. PubMed ID: 26062436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duration of the protective immune response after prime and booster vaccination of yearlings with a live modified cold-adapted viral vaccine against equine influenza.
    Tabynov K; Kydyrbayev Zh; Ryskeldinova Sh; Assanzhanova N; Sansyzbay A
    Vaccine; 2014 May; 32(25):2965-71. PubMed ID: 24726250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.
    Nicholson KG; Colegate AE; Podda A; Stephenson I; Wood J; Ypma E; Zambon MC
    Lancet; 2001 Jun; 357(9272):1937-43. PubMed ID: 11425416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth properties and immunogenicity of a virus generated by reverse genetics for an inactivated equine influenza vaccine.
    Ohta M; Bannai H; Kambayashi Y; Tamura N; Tsujimura K; Yamayoshi S; Kawaoka Y; Nemoto M
    Equine Vet J; 2022 Jan; 54(1):139-144. PubMed ID: 33527477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
    Daly JM; Yates PJ; Newton JR; Park A; Henley W; Wood JL; Davis-Poynter N; Mumford JA
    Vaccine; 2004 Sep; 22(29-30):4101-9. PubMed ID: 15364463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic methods applied to analysis of an outbreak of equine influenza in a riding school in which vaccine failure occurred.
    van Maanen C; van Essen GJ; Minke J; Daly JM; Yates PJ
    Vet Microbiol; 2003 Jun; 93(4):291-306. PubMed ID: 12713892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination.
    Nelson KM; Schram BR; McGregor MW; Sheoran AS; Olsen CW; Lunn DP
    Vaccine; 1998 Aug; 16(13):1306-13. PubMed ID: 9682395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of primary vaccination regimes for equine influenza: working towards an evidence-based regime.
    Cullinane A; Gildea S; Weldon E
    Equine Vet J; 2014 Nov; 46(6):669-73. PubMed ID: 24237177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of antibodies to the nonstructural protein (NS1) of influenza A virus allows distinction between vaccinated and infected horses.
    Ozaki H; Sugiura T; Sugita S; Imagawa H; Kida H
    Vet Microbiol; 2001 Sep; 82(2):111-9. PubMed ID: 11423202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination.
    Soboll G; Hussey SB; Minke JM; Landolt GA; Hunter JS; Jagannatha S; Lunn DP
    Vet Immunol Immunopathol; 2010 May; 135(1-2):100-107. PubMed ID: 20018384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus.
    Mumford JA; Wood JM; Folkers C; Schild GC
    Epidemiol Infect; 1988 Jun; 100(3):501-10. PubMed ID: 2837409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of age on serum antibody titers after rabies and influenza vaccination in healthy horses.
    Muirhead TL; McClure JT; Wichtel JJ; Stryhn H; Frederick Markham RJ; McFarlane D; Lunn DP
    J Vet Intern Med; 2008; 22(3):654-61. PubMed ID: 18466246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and protective efficacy of inactivated equine influenza (H3N8) virus vaccine in murine model.
    Pavulraj S; Virmani N; Bera BC; Joshi A; Anand T; Virmani M; Singh R; Singh RK; Tripathi BN
    Vet Microbiol; 2017 Oct; 210():188-196. PubMed ID: 29103691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimising vaccination strategies in equine influenza.
    Park AW; Wood JL; Newton JR; Daly J; Mumford JA; Grenfell BT
    Vaccine; 2003 Jun; 21(21-22):2862-70. PubMed ID: 12798628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Area under the curve calculations as a tool to compare the efficacy of equine influenza vaccines--a retrospective analysis of three independent field trials.
    Heldens JG; Weststrate MW; van den Hoven R
    J Immunol Methods; 2002 Jun; 264(1-2):11-7. PubMed ID: 12191504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
    Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
    Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease.
    Newton JR; Daly JM; Spencer L; Mumford JA
    Vet Rec; 2006 Feb; 158(6):185-92. PubMed ID: 16474051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Equine influenza vaccine efficacy: the significance of antigenic variation.
    Yates P; Mumford JA
    Vet Microbiol; 2000 May; 74(1-2):173-7. PubMed ID: 10799789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.